Adagio Medical Holdings Statistics
Total Valuation
ADGM has a market cap or net worth of $27.76 million. The enterprise value is $32.42 million.
Important Dates
The next estimated earnings date is Thursday, May 14, 2026, before market open.
| Earnings Date | May 14, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
ADGM has 22.21 million shares outstanding. The number of shares has increased by 148.37% in one year.
| Current Share Class | 22.21M |
| Shares Outstanding | 22.21M |
| Shares Change (YoY) | +148.37% |
| Shares Change (QoQ) | +34.33% |
| Owned by Insiders (%) | 1.36% |
| Owned by Institutions (%) | 11.43% |
| Float | 4.81M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | 2.24 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio History Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 2.44, with a Debt / Equity ratio of 1.75.
| Current Ratio | 2.44 |
| Quick Ratio | 2.08 |
| Debt / Equity | 1.75 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -7.53 |
Financial Efficiency
Return on equity (ROE) is -155.25% and return on invested capital (ROIC) is -38.90%.
| Return on Equity (ROE) | -155.25% |
| Return on Assets (ROA) | -29.84% |
| Return on Invested Capital (ROIC) | -38.90% |
| Return on Capital Employed (ROCE) | -62.51% |
| Weighted Average Cost of Capital (WACC) | 7.14% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$313,550 |
| Employee Count | 80 |
| Asset Turnover | n/a |
| Inventory Turnover | 0.32 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +48.81% in the last 52 weeks. The beta is 0.04, so ADGM's price volatility has been lower than the market average.
| Beta (5Y) | 0.04 |
| 52-Week Price Change | +48.81% |
| 50-Day Moving Average | 1.04 |
| 200-Day Moving Average | 1.25 |
| Relative Strength Index (RSI) | 63.30 |
| Average Volume (20 Days) | 62,919 |
Short Selling Information
The latest short interest is 15,249, so 0.07% of the outstanding shares have been sold short.
| Short Interest | 15,249 |
| Short Previous Month | 74,890 |
| Short % of Shares Out | 0.07% |
| Short % of Float | 0.32% |
| Short Ratio (days to cover) | 0.36 |
Income Statement
| Revenue | n/a |
| Gross Profit | -684,000 |
| Operating Income | -21.89M |
| Pretax Income | -25.08M |
| Net Income | -25.08M |
| EBITDA | -20.92M |
| EBIT | -21.89M |
| Earnings Per Share (EPS) | -$1.51 |
Full Income Statement Balance Sheet
The company has $17.11 million in cash and $21.76 million in debt, with a net cash position of -$4.65 million or -$0.21 per share.
| Cash & Cash Equivalents | 17.11M |
| Total Debt | 21.76M |
| Net Cash | -4.65M |
| Net Cash Per Share | -$0.21 |
| Equity (Book Value) | 12.40M |
| Book Value Per Share | 0.56 |
| Working Capital | 11.85M |
Full Balance Sheet Cash Flow
In the last 12 months, operating cash flow was -$19.01 million and capital expenditures -$374,000, giving a free cash flow of -$19.39 million.
| Operating Cash Flow | -19.01M |
| Capital Expenditures | -374,000 |
| Depreciation & Amortization | 970,000 |
| Net Borrowing | n/a |
| Free Cash Flow | -19.39M |
| FCF Per Share | -$0.87 |
Full Cash Flow Statement Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
ADGM does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -148.37% |
| Shareholder Yield | -148.37% |
| Earnings Yield | -90.35% |
| FCF Yield | -69.83% |
Analyst Forecast
The average price target for ADGM is $4.00, which is 220.00% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $4.00 |
| Price Target Difference | 220.00% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 1 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock Forecasts Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 1 |